Discover open access scientific publications

Pre-Transplant Azacitidine and Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes of One Hundred Fifty-Nine Patients Up to Age Seventy-Five With Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)